UNSPSC 51182066: Testosterone benzoate

This classification denotes an androgen with the molecular formula C26H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 387187KT3E, chemically known as androst-4-en-3-one, 17-(benzoyloxy)-, (17.beta.)-, but more generally known as testosterone benzoate, which bears US NIH Compound Identifier 101474. European Medicines Agency schedules testosterone benzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10937MIG.

Most nations, for tariff purposes, schedule testosterone benzoate under HS 29372900. SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4CCCCC4)CCC5=CC(=O)CC[C@]35C.

UNSPSC 51182066 Testosterone benzoate, a Commodity code, encompasses pharmaceutical active ingredients and finished-dose products supplied to state and local government healthcare and correction facilities. State and local government procurement under this code focuses on multi-source generic pharmaceuticals and over-the-counter products distributed through cooperative purchasing agreements that aggregate demand across participating jurisdictions and their healthcare delivery networks. The scope includes manufacturers supplying National Drug Code-identified products with specified strength, dosage form, packaging configurations, and manufacturing detail, with vendors required to maintain current Good Manufacturing Practices certification and Drug Supply Chain Security Act compliance, establish relationships with authorized wholesale distributors, and offer flexible pricing structures ranging from flat-fee to wholesale acquisition cost-minus formats. Issuing bodies soliciting under this code include state departments of administration and health, counties, municipalities, and special-purpose healthcare districts that participate in multi-state cooperative purchasing alliances; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a standout repeat buyer aggregating volume across state and local government facilities in multiple states.

Recent activity centers on multi-state cooperative purchasing driven by MMCAP. The Minnesota Department of Administration issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota, Oregon, and other MMCAP member jurisdictions. Proposals were due March 26, 2026, with awarded vendors effective July 1, 2026; evaluation weighted price competitiveness at 75 percent and required vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with chargeback systems in place. Vendors must carry commercial general liability of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million, and agree to a 3 percent administrative fee on all contract purchases with performance penalties of $200 to $1,500 per violation.